Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis
The addition of PBT to Ate/Bev was associated with improved treatment response and survival in patients with uHCC without compromising safety of the treatment. This combined approach may represent a promising therapeutic strategy that warrants prospective validation.
Authors
- Chao‐Hung Hung (ORCID: https://orcid.org/0000-0003-1646-9519)
- Yen‐Hao Chen (ORCID: https://orcid.org/0000-0002-5622-5490)
- Yuan‐Hung Kuo (ORCID: https://orcid.org/0000-0003-0185-1846)
- Yi‐Chung Hsieh (ORCID: https://orcid.org/0000-0002-1191-4399)
- Eric Yi-Liang Shen (ORCID: https://orcid.org/0000-0003-2910-1393)
- Chen‐Chun Lin (ORCID: https://orcid.org/0000-0002-2907-2679)
- Jing‐Houng Wang (ORCID: https://orcid.org/0000-0002-4916-9814)
- Po‐Ting Lin (ORCID: https://orcid.org/0000-0002-7486-8908)
- Wei Teng (ORCID: https://orcid.org/0000-0001-5663-1440)
- Chun‐Yen Lin (ORCID: https://orcid.org/0000-0003-3007-3190)
- Jen-Yu Cheng (ORCID: https://orcid.org/0000-0002-5080-0394)
- Wei‐Ting Chen (ORCID: https://orcid.org/0000-0001-8246-0219)
- Tsung‐Han Wu (ORCID: https://orcid.org/0000-0001-8455-8009)
- Chung‐Wei Su (ORCID: https://orcid.org/0000-0003-2778-3618)
- Shi‐Ming Lin (ORCID: https://orcid.org/0000-0001-7527-6181)
- Bing-Shen Huang
Institutions
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- Taipei City Hospital (TW)
Publication Details
- Journal
- Liver International
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1111/liv.70465
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Chang Gung Medical Foundation
- Kaohsiung Chang Gung Memorial Hospital